The Beauty Health Company (NASDAQ:SKIN) Stock Has Consensus Target Price of $1.38 According to Brokerages

The Beauty Health Company (NASDAQ:SKIN) has earned a consensus rating of “Hold” from the seven research firms that are presently covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell rating, five have given a hold rating and one has assigned a buy rating to the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $1.38.

A number of research analysts recently commented on the stock. Zacks Research lowered shares of Beauty Health from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 20th. Weiss Ratings cut Beauty Health from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, July 23rd. Finally, TD Cowen decreased their target price on Beauty Health from $1.00 to $0.90 and set a “hold” rating on the stock in a research report on Wednesday, August 12th.

Beauty Health Price Performance

NASDAQ:SKIN opened at $0.55 on Friday. Beauty Health has a 12-month low of $0.50 and a 12-month high of $1.74. The firm has a market capitalization of $71.58 million, a price-to-earnings ratio of -2.50 and a beta of 1.05. The stock’s 50 day moving average price is $0.66 and its two-hundred day moving average price is $0.74. The company has a quick ratio of 1.48, a current ratio of 1.76 and a debt-to-equity ratio of 4.36.

Beauty Health’s stock is going to reverse split on Wednesday, October 14th. The 1-20 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the market closes on Tuesday, October 13th.

Beauty Health (NASDAQ:SKIN) last issued its quarterly earnings data on Thursday, August 6th. The company reported ($0.02) earnings per share for the quarter, meeting the consensus estimate of ($0.02). The company had revenue of $72.11 million for the quarter, compared to analyst estimates of $74.45 million. Beauty Health had a negative net margin of 9.79% and a negative return on equity of 47.83%. On average, analysts anticipate that Beauty Health will post -0.16 earnings per share for the current year.

Institutional Trading of Beauty Health

Institutional investors have recently added to or reduced their stakes in the company. Bank of America Corp DE increased its position in Beauty Health by 19.2% during the 1st quarter. Bank of America Corp DE now owns 106,242 shares of the company’s stock worth $95,000 after buying an additional 17,088 shares during the period. Renaissance Technologies LLC boosted its position in shares of Beauty Health by 29.6% in the first quarter. Renaissance Technologies LLC now owns 283,791 shares of the company’s stock valued at $253,000 after acquiring an additional 64,900 shares during the period. Capricorn Fund Managers Ltd acquired a new position in shares of Beauty Health in the first quarter valued at about $17,270,000. Finally, Diversified Trust Co acquired a new position in shares of Beauty Health in the first quarter valued at about $25,000. 93.26% of the stock is currently owned by institutional investors.

About Beauty Health

BeautyHealth is a global health and beauty company focused on creating technology-enabled products and experiences for skin health. Its primary brand is Hydrafacial, which offers non-invasive skin treatments that combine cleansing, exfoliation, extraction and hydration with professional-grade devices, serums and treatment boosters.

The company also provides products and systems designed for complementary aesthetic and wellness applications, including Syndeo, a connected Hydrafacial delivery system; Keravive, a scalp-health treatment; and SkinStylus, a microneedling platform.